Princeton Innovations Inc is a pharmaceutical and biotechnology innovation and development partner providing scientific, technical, and strategic support to pharma and biotech companies across the drug development lifecycle.

Our capabilities include formulation and process development, analytical method development and validation, stability studies, scale-up, technology transfer, and CMC strategy, supporting new product development programs from early research through clinical and commercial stages.

We work closely with our clients as an extension of their internal development teams, enabling seamless collaboration, rapid decision-making, and customized development strategies. Our agile operating model allows us to deliver faster timelines and cost-efficient solutions compared to large CDMOs, while maintaining scientific rigor and regulatory alignment.

We leverage data analytics and AI-enabled tools to support formulation optimization, process understanding, and data-driven development decisions. In parallel, we collaborate with academic institutions, expert consultants, CMOs, and global partners to address complex technical challenges and enhance development outcomes.

Princeton Innovations Inc is committed to advancing robust, scalable, and scientifically sound drug products through close partnership, technical excellence, and efficient execution.

📩 Contact: info@prinlabs.com
 for more information.

Princeton Innovations Inc.

Org chart

Teams

Offices